Emibetuzumab (Anti-HGFR / c-Met)Emibetuzumab (Anti-HGFR / c-Met)
Move your mouse over image or click to enlarge

Emibetuzumab (Anti-HGFR / c-Met)

Emibetuzumab (Anti-HGFR / c-Met) is a humanized bivalent MET antibody targeting both HGF-dependent and HGF-independent MET pathway activation and tumor growth. It can be used in study of cancer. MW :144.56 KD.
Cat# Size Price Qty Buy
A2662-1mg*25 1mg*25
£1,941.00
A2662-1mg*5 1mg*5
£647.00
A2662-1mg 1mg
£221.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2662

Related Documents